Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective

Overview of attention for article published in BMC Ophthalmology, May 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,459 followers.

RT @TomSChangMD: Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective http…

Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective https://t.co/6BqoRuxzYE #Ophthalmology #Eyecare #Health #Healthcare #Medical #Doctor #Doctors #MD

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.